A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

July 31, 2006

Conditions
Cardiovascular, Neurologic (Spine), and General Surgery
Interventions
DRUG

Human Thrombin

DRUG

Bovine Thrombin

Trial Locations (17)

18103

Lehigh Valley Hospital, Allentown

19107

Thomas Jefferson University Hospital, Philadelphia

21218

Union Memorial Hospital, Baltimore

35235

Alabama Clinical Therapeutics, Birmingham

37920

University of Tennessee Medical Center, Knoxville

49048

Borgess Research Institute, Kalamazoo

54913

Neurospine Center of Wisconsin, Appleton

63110

Washington University School of Medicine, St Louis

68105

University of Nebrask Medical Center, Omaha

70121

Ochsner Clinic, New Orleans

76508

Scott and White Hospital, Temple

77030

MD Anderson Cancer Center, Houston

University of Texas Health Science Center at Houston Medical School, Houston

85741

Northwest NeuroSpecialists, PPLC, Tucson

90404

Vacular Surgery Associates, Santa Monica

94305

Stanford University Medical Center, Stanford

08103

Cooper University Hospital, Camden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

OMRIX Biopharmaceuticals

INDUSTRY

lead

Ethicon, Inc.

INDUSTRY

NCT00196534 - A Study to Compare Human Thrombin Against Bovine Thrombin in Its Ability to Stop Bleeding After Surgery | Biotech Hunter | Biotech Hunter